Friday, 25 September 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 11, 2026

Want to Own SpaceX Stock Before Its Blockbuster IPO? Here Are 3 Ways Investors Can Buy Right Now.

View original at nasdaq.com
“In 2026, SpaceX was valued at $1.25 trillion when it merged with xAI, meaning Alphabet's stake is now worth over $100 billion.”
Verbatim excerpt from the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The current valuation of 30 times earnings looks reasonable for Alphabet

    60% confidence
  • Elon Musk hopes to raise $75 billion in the IPO, more than double the current record

    60% confidence
  • Baron Partners Fund seeks capital appreciation through investments in growth companies of any size with significant long-term potential

    60% confidence
  • SpaceX is seeking a $1.75 trillion valuation in its IPO

    60% confidence
  • Wall Street expects Alphabet's earnings to increase at 15% annually over the next three years

    60% confidence
  • Ark Venture Fund seeks to democratize venture capital, offering all investors access to what we believe are the most innovative companies

    60% confidence

Data points we hold from this source

SpaceX · market cap1250000000000.0 USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI Agents Scale Up Through Partnerships and Funding, But Data Readiness Lags Ambition
A wave of vertical AI-agent startups (Swarm, Veridox, Avallon AI, DA2, F2, Earthian, Meanwhile, Covecta, Penguin AI, Maisa AI) is being funded and profiled just as major infrastructure players — Microsoft/Mistral, Siemens/NVIDIA, and Manulife/Microsoft — cement enterprise AI governance and compute partnerships. Yet a Google Cloud report shows AI agents still lack access to the majority of company data (only 45% on average), and insider selling at incumbent C3.ai signals investor caution even as adoption intent (100% planned agentic AI use within two years) races ahead of actual data infrastructure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,984
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,984 facts checked against source5,306 source documents archived
Query this data → isubstrate.com